Medical soft robotics constitutes a rapidly developing field in the treatment of cardiovascular
diseases, with a promising future for millions of patients suffering from heart failure …

Background: Sarcopenia is a degenerative condition characterised by the loss of skeletal
muscle mass and strength. Its impact on cardiac surgery outcomes remains poorly …

Background Obesity is a known cardiovascular risk factor and associated with higher
postoperative complication rates in patients undergoing cardiac surgery. In heart failure …

For adults with advanced heart failure, class II/III obesity (body mass index≥ 35 kg/m2)
represents major challenges, and it is even considered a contraindication for heart …

For adults with advanced heart failure, class II/III obesity (body mass index≥ 35 kg/m 2)
represents major challenges, and it is even considered a contraindication for heart …

Background: Left ventricular assist devices (LVAD) are increasingly being used as a therapy
for advanced heart failure, both as a bridge to heart transplant and, given the rapid …

Abstract Purpose of Review This review aims to synthesize the latest evidence focused on
therapies related to comorbid obesity and heart failure, with particular attention to lifestyle …

Abstract Purpose of the Review Progressive intravascular, interstitial, and alveolar fluid
overload underlies the transition from compensated to acutely decompensated heart failure …

Objective There is a paucity of data assessing the impact of nutritional status on outcomes in
patients supported with the HeartMate 3 (HM3) left ventricular assist device (LVAD) …

Background Body mass index (BMI) is an important consideration for transplant‐eligible left
ventricular assist device (LVAD) recipients. LVAD therapy's impact on BMI is unclear. We …